Asymchem Laboratories, Inc., a leading contract development and manufacturing organisation (CDMO), is headquartered in the United States and operates extensively across Asia and Europe. Founded in 1997, Asymchem has established itself as a key player in the pharmaceutical and biotechnology sectors, specialising in integrated services that encompass drug development, manufacturing, and supply chain management. The company is renowned for its innovative approach to process development and its commitment to quality, offering a range of core services including active pharmaceutical ingredient (API) production and formulation development. Asymchem's unique capabilities in continuous flow chemistry and advanced manufacturing technologies set it apart in a competitive market. With a strong track record of successful partnerships and a focus on sustainability, Asymchem Laboratories continues to solidify its position as a trusted partner for global pharmaceutical companies.
How does Asymchem Laboratories, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Asymchem Laboratories, Inc.'s score of 23 is lower than 69% of the industry. This can give you a sense of how well the company is doing compared to its peers.
As of the latest available data, Asymchem Laboratories, Inc. does not report any specific carbon emissions figures, indicating a lack of publicly disclosed emissions data. Consequently, there are no recorded Scope 1, 2, or 3 emissions figures to analyse. Furthermore, the company has not established any documented reduction targets or commitments to climate initiatives, such as those outlined by the Science Based Targets initiative (SBTi) or other industry standards. This absence of data suggests that Asymchem Laboratories may not currently have formalised climate commitments or reduction strategies in place. In the context of the pharmaceutical and chemical manufacturing industry, where sustainability and emissions reduction are increasingly critical, Asymchem Laboratories may need to consider developing and communicating clear climate commitments to align with industry best practices and stakeholder expectations.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Asymchem Laboratories, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

